Reduced lopinavir exposure during pregnancy-Reference-Cited by-同舟云学术

Reduced lopinavir exposure during pregnancy

Published:2006-10-03 Issue:15 Volume:20 Page:1931-1939
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Stek Alice M,Mirochnick Mark,Capparelli Edmund,Best Brookie M,Hu Chengcheng,Burchett Sandra K,Elgie Carol,Holland Diane T,Smith Elizabeth,Tuomala Ruth,Cotter Amanda,Read Jennifer S

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference9 articles.

1. ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results;Murphy;AIDS,2001

2. Quality assurance program for clinical measurement of antiretrovirals: AIDS clinical trials group proficiency testing program for pediatric and adult pharmacology laboratories;Holland;Antimicrob Agents Chemother,2004

3. Pharmacokinetics of saquinavir-SGC in HIV-infected pregnant women;Acosta;HIV Clin Trials,2001

4. Safety and efficacy of saquinavir soft-gelatin capsules + zidovudine + optional lamivudine in pregnancy and prevention of vertical HIV transmission;Vithayasai;J Acquir Immune Defic Syndr,2002

5. Safety and pharmacokinetics of nelfinavir co-administered with zidovudine and lamivudine in infants during the first 6 weeks of life;Mirochnick;J Acquir Immune Defic Syndr,2005

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Virological Outcomes Among Pregnant Women Receiving Antiretroviral Treatment in the Amhara Region, North West Ethiopia;HIV/AIDS - Research and Palliative Care;2023-05

2. Principles of Obstetric Pharmacology;Obstetrics and Gynecology Clinics of North America;2023-03

3. Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV: Results From IMPAACT P1026s;JAIDS Journal of Acquired Immune Deficiency Syndromes;2022-07-01

4. Placental transfer and vascular effects of pharmaceutical drugs in the human placenta ex vivo: A review;Placenta;2022-05

5. Magnitude of Drug–Drug Interactions in Special Populations;Pharmaceutics;2022-04-04